Veru Inc Q3 2024 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Yi Chen - H.C. Wainwright - Analyst : Thank you for taking my questions. Assuming positive results coming out of the Phase 2b quality study, how soon can you advance the candidate to the next step and whether you plan to find a partnership for a potential registration study.

Question: Yi Chen - H.C. Wainwright - Analyst : Got it. That's helpful. Thank you.

Question: William Wood - B. Riley Securities - Analyst : Appreciate you taking my questions and congratulations on the quarter. Just looking for a little extra color here on what we might expect in January for the top line data. Is this going to be like simply lean mass loss being reported? Or will you provide any extra details on the body weight loss and/or the fat loss war specifically the functional improvements?

Question: William Wood - B. Riley Securities - Analyst : Got it. Very helpful. And maybe actually just a quick question. I believe you mentioned that you're going to have a presentation at obesity week. You mentioned the abstract. Is this going to be, I would say, unseen data from past clinical trials? Or is it going to be a little bit of what we've been seeing or potentially what we've seen already?

Question: William Wood - B. Riley Securities - Analyst : Okay. Helpful. That's it. I'll jump back in queue. Thank you so much.